Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2020-11-20 4:32 pm Unchanged | 13D | KEROS THERAPEUTICS INC KROS | ORBIMED ADVISORS LLC | 1,268,734 5.5% | 0 (Unchanged) | View |
2020-11-18 2:42 pm Unchanged | 13D | ORIC PHARMACEUTICALS INC ORIC | ORBIMED ADVISORS LLC | 2,765,717 7.8% | 0 (Unchanged) | View |
2020-11-12 5:15 pm Purchase | 13D | AERPIO PHARMACEUTICALS INC ARPO | ORBIMED ADVISORS LLC | 5,193,946 11% | 5,193,946 (New Position) | View |
2020-11-06 5:12 pm Purchase | 13D | GALECTO INC GLTO | ORBIMED ADVISORS LLC | 2,771,444 11.3% | 2,771,444 (New Position) | View |
2020-10-22 8:40 pm Unchanged | 13D | BELLUS HEALTH INC BLU | ORBIMED ADVISORS LLC | 3,954,800 5.2% | 0 (Unchanged) | View |
2020-10-13 9:14 pm Unchanged | 13D | SPRINGWORKS THERAPEUTICS INC C SWTX | ORBIMED ADVISORS LLC | 7,406,307 15.5% | 0 (Unchanged) | View |
2020-10-07 5:08 pm Purchase | 13D | ARCUTIS BIOTHERAPEUTICS INC CO ARQT | ORBIMED ADVISORS LLC | 4,267,564 9.9% | 200,000 (+4.92%) | View |
2020-10-06 5:16 pm Purchase | 13D | LOGICBIO THERAPEUTICS INC LOGC | ORBIMED ADVISORS LLC | 4,126,972 13% | 639,212 (+18.33%) | View |
2020-10-05 5:28 pm Purchase | 13D | GRAYBUG VISION INC GRAY | ORBIMED ADVISORS LLC | 4,163,347 20.7% | 4,163,347 (New Position) | View |
2020-10-05 5:27 pm Purchase | 13D | XTANT MED HLDGS INC XTNT | ORBIMED ADVISORS LLC | 72,810,381 94.8% | 58,796,060 (+419.54%) | View |
2020-10-05 5:23 pm Purchase | 13D | PMV PHARMACEUTICALS INC PMVP | ORBIMED ADVISORS LLC | 6,589,330 14.7% | 6,589,330 (New Position) | View |
2020-10-05 5:17 pm Purchase | 13D | PRELUDE THERAPEUTICS INC PRLD | ORBIMED ADVISORS LLC | 14,805,377 33.9% | 14,805,377 (New Position) | View |
2020-09-23 5:00 pm Sale | 13D | 89BIO INC ETNB | ORBIMED ADVISORS LLC | 1,864,721 9.4% | -137,500 (-6.87%) | View |
2020-09-18 5:12 pm Purchase | 13D | RESTORBIO INC TORC | ORBIMED ADVISORS LLC | 5,513,015 28.1% | 682,628 (+14.13%) | View |
2020-08-19 5:14 pm Purchase | 13G | ARVINAS INC ARVN | ORBIMED ADVISORS LLC | 1,177,483 4.1% | 188,683 (+19.08%) | View |
2020-08-18 4:31 pm Purchase | 13D | ACUTUS MED INC AFIB | ORBIMED ADVISORS LLC | 5,810,525 20.9% | 5,810,525 (New Position) | View |
2020-07-30 6:26 pm Unchanged | 13D | ALPINE IMMUNE SCIENCES INC ALPN | ORBIMED ADVISORS LLC | 3,816,206 16% | 0 (Unchanged) | View |
2020-07-27 5:57 pm Purchase | 13G | PANDION THERAPEUTICS INC PAND | ORBIMED ADVISORS LLC | 1,040,825 3.6% | 1,040,825 (New Position) | View |
2020-07-16 5:12 pm Sale | 13D | ALECTOR INC ALEC | ORBIMED ADVISORS LLC | 2,725,313 3.5% | -2,776,735 (-50.47%) | View |
2020-07-13 4:20 pm Unchanged | 13D | 89BIO INC ETNB | ORBIMED ADVISORS LLC | 2,002,221 11.9% | 0 (Unchanged) | View |